ArticleEuropean journal of clinical pharmacology2024

The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line.

Mustafa Korkmaz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.